Back to search

Somatropin Treatment to Final Height in Turner Syndrome

NCT00191113

PHASE3INTERVENTIONAL
Eli Lilly and Company
154 participants
Started 1989-02 · Completed 2007-12
Status: Completed (as of 12-23-2025)

Conditions

Turner Syndrome

Linked Papers (from SciSciNet-V2)

Total Papers2
Background
1
Result
0
Derived
0
Unknown
1

Total Citations Per Year

Brief Summary

A randomized, controlled trial in girls with Turner syndrome at least 7 years old and younger than 13 at study entry, to determine the efficacy and safety of Humatrope (somatropin) treatment in promoting linear growth to final height.

Sort by:

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked